4
Changes in Ownership
Aclaris Therapeutics, Inc. Filed Acc 0001209191-20-002767
Options or other derivatives
- Director acquired 22,000 shares (grant or award)
From the SEC's structured data for this filing
Aclaris Therapeutics, Inc. Filed Acc 0001209191-20-002767
Options or other derivatives
From the SEC's structured data for this filing
Connection lost
Reconnecting…
Cite Filings isn't responding
Reconnecting…